Gufic Biosciences Limited (GUFICBIO)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
216.8
0.9(0.42%)

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

Pricing Updates

TODAY'S HIGH

222.7

TODAY'S LOW

210.6

52 WEEK HIGH

290

52 WEEK LOW

192.15

Major Holders

% of Shares Held by
All Insider

78.08%

% of Shares Held by
Institutions

1.98%

% of Float Held by
Institutions

9.05%

Number of Institutions
Holding Shares

6

Company Overview

MARKET CAP

2103.20 Cr.

ETERPRISE VALUE

2227.06 Cr.

NO. OF SHARES

9.69 Cr.

BOOK VALUE

31.991

DIV. YIELD

0.1%

DEBT

185.45 Cr.

GROSS PROFIT

358.45 Cr.

CASH

46.26 Cr.

REVENUE

674.37 Cr.

REVENUE/SHARE

69.569

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0000
Change To Liabilities34.15 Cr.90.19 Lakhs27.42 Cr.1.64 Cr.
Total cashflows from Investing Activities-95.93 Cr.-8.50 Cr.-42.53 Cr.-12.99 Cr.
Net Borrowings2.85 Cr.-64.83 Cr.10.01 Cr.18.06 Cr.
Total Cash from Financing Activities-3.10 Cr.-78.61 Cr.-4.20 Cr.7.70 Cr.
Other Liabilities0000
Total Assets0000
Net Income95.84 Cr.44.23 Cr.22.68 Cr.21.94 Cr.
Change in Cash5.40 Cr.1.94 Cr.36.49 Lakhs-7.76 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities104.44 Cr.89.06 Cr.47.10 Cr.5.20 Cr.
Depreciation17.13 Cr.16.27 Cr.13.82 Cr.4.59 Cr.
Other Cashflows from Investing Activities-7.20 Cr.5.70 Cr.-2.69 Cr.8.45 Lakhs
Dividends Paid-92.11 Lakhs-36.29 Lakhs-48.75 Lakhs-38.75 Lakhs
Change to Inventory-21.16 Cr.28.05 Cr.-8.22 Cr.-8.36 Lakhs
Change to Account Receivables-23.19 Cr.-18.99 Cr.-16.71 Cr.-35.08 Cr.
Other Cashflows from Financing Activities-5.02 Cr.-13.41 Cr.-13.73 Cr.-9.96 Cr.
Change to Net Income1.67 Cr.18.57 Cr.8.07 Cr.12.14 Cr.
Capital Expenditures-88.80 Cr.-14.21 Cr.-39.84 Cr.-13.08 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax126.83 Cr.57.71 Cr.30.12 Cr.35.34 Cr.
Minority InterestNoneNoneNoneNone
Net Income128.58 Cr.67.65 Cr.38.53 Cr.41.34 Cr.
Selling General Administrative85.61 Cr.69.11 Cr.63.73 Cr.52.52 Cr.
Gross Profit367.19 Cr.231.18 Cr.193.79 Cr.168.55 Cr.
Ebit128.58 Cr.67.65 Cr.38.53 Cr.41.34 Cr.
Operating Income128.58 Cr.67.65 Cr.38.53 Cr.41.34 Cr.
Other Operating Expenses135.86 Cr.78.12 Cr.77.66 Cr.70.04 Cr.
Interest Expense-4.84 Cr.-11.76 Cr.-12.67 Cr.-10.02 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense30.99 Cr.13.47 Cr.7.43 Cr.13.40 Cr.
Total Revenue779.15 Cr.487.69 Cr.378.83 Cr.350.76 Cr.
Total Operating Expenses650.57 Cr.420.04 Cr.340.29 Cr.309.42 Cr.
Cost of Revenue411.96 Cr.256.51 Cr.185.03 Cr.182.21 Cr.
Total Other Income Expense Net-1.74 Cr.-9.94 Cr.-8.41 Cr.-5.99 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.95.84 Cr.44.23 Cr.22.68 Cr.21.94 Cr.
Net Income Applicable to Common Shares95.84 Cr.44.23 Cr.22.68 Cr.21.94 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets61.02 Lakhs44.51 Lakhs53.60 Lakhs34.40 Lakhs
Capital Surplus0026.25 Lakhs16.45 Lakhs
Total Liabilities252.28 Cr.218.62 Cr.278.19 Cr.204.19 Cr.
Stock Holder Equity269.11 Cr.173.43 Cr.129.32 Cr.75.34 Cr.
Minority Interest0000
Other Liabilities36.61 Cr.8.14 Cr.7.30 Cr.9.55 Cr.
Total Assets521.40 Cr.392.06 Cr.407.51 Cr.279.53 Cr.
Common Stock9.69 Cr.9.69 Cr.9.69 Cr.7.78 Cr.
Retained Earnings095.03 Cr.50.92 Cr.67.32 Cr.
Other Liabilities17.57 Cr.16.71 Cr.12.67 Cr.6.53 Cr.
Good Will002.10 Lakhs2.24 Lakhs
Treasury Stock259.42 Cr.68.71 Cr.68.43 Cr.7.14 Lakhs
Other Assets44.59 Cr.18.10 Cr.21.01 Cr.12.94 Cr.
Cash26.57 Cr.6.20 Cr.4.26 Cr.3.66 Cr.
Current Liabilities186.98 Cr.163.66 Cr.239.77 Cr.186.34 Cr.
Long Term Asset Charges0063.60 Lakhs68.96 Lakhs
Short Long Term Debt03.59 Cr.4.09 Cr.1.74 Cr.
Other Stockholder Equity259.42 Cr.68.71 Cr.68.43 Cr.7.14 Lakhs
Property Plant Equipment155.43 Cr.112.92 Cr.112.63 Cr.33.70 Cr.
Total Cur. Assets320.75 Cr.260.58 Cr.273.30 Cr.232.51 Cr.
Long Term Investments75 k75 k75 k50 k
Net Tangible Assets268.50 Cr.172.99 Cr.128.76 Cr.74.98 Cr.
Short Term Investments0000
Net Receivables151.93 Cr.124.75 Cr.107.35 Cr.103.91 Cr.
Long Term Debt47.39 Cr.35.42 Cr.19.54 Cr.11.31 Cr.
Inventory115.56 Cr.94.40 Cr.122.46 Cr.94.28 Cr.
Accounts Payable140.95 Cr.113.02 Cr.117.06 Cr.77.80 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account